Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3

发表于 2026-9-9 17:30:59

期刊：Science Translational Medicine

文献作者：Dionysos Slaga; Diego Ellerman; T. Noelle Lombana; Rajesh Vij; Ji Li; Maria Hristopoulos; Robyn Clark; Jennifer Johnston; Amy Shelton; Elaine Mai; Kapil Gadkar; Amy A. Lo; James T. Koerber; Klara Totpal; Rodney Prell; Genee Lee; Christoph Spiess; Teemu T. Junttila

出版日期：2018-10-17

DOI号：10.1126/scitranslmed.aat5775

下载链接：https://www.science.org/doi/pdf/10.1126/scitranslmed.aat5775

文献链接：https://doi.org/10.1126/scitranslmed.aat5775

当前文献来源于 American Association for the Advancement of Science (AAAS)。

备注信息：

发表于 2026-9-9 17:31:00

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[AAAS] Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3 一键复制